Search research articles
Contact Us
Filters
Showing results (71-80 of 94) with videos related to
Page
of 10
Sort By:
European Journal of Haematology
|
May 1, 1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapy
C Fermé, P Brice, E Bourstyn, et al.
Journal of Neurology
|
May 10, 2017
Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy
M Baron, P Lozeron, S Harel, et al.
Leukemia Research
|
February 13, 2001
Primary plasma cell leukaemia: a report of 18 cases
R Costello, D Sainty, R Bouabdallah, et al.
Leukemia
|
January 15, 2010
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
H Avet-Loiseau, J Soulier, J-P Fermand, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 30, 2018
Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia
A L Roupie, M Battistella, A Talbot, et al.
Transfusion
|
March 10, 2001
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization
C Dosquet, Y Chen, J Makke, et al.
Blood
|
October 27, 1998
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial
J P Fermand, P Ravaud, S Chevret, et al.
Leukemia
|
August 27, 2005
Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients
J Tamburini, V Lévy, C Chaleteix, et al.
Bone Marrow Transplantation
|
April 20, 2010
Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
L Karlin, B Arnulf, S Chevret, et al.
La Revue De Medecine Interne
|
May 2, 2017
[Classification and therapeutic management of monoclonal gammopathies of renal significance]
V Javaugue, I Bouteau, C Sirac, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 94) with videos related to
Sort By:
Page
of 10
European Journal of Haematology
|
May 1, 1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapy
C Fermé, P Brice, E Bourstyn, et al.
Journal of Neurology
|
May 10, 2017
Plasma exchanges for severe acute neurological deterioration in patients with IgM anti-myelin-associated glycoprotein (anti-MAG) neuropathy
M Baron, P Lozeron, S Harel, et al.
Leukemia Research
|
February 13, 2001
Primary plasma cell leukaemia: a report of 18 cases
R Costello, D Sainty, R Bouabdallah, et al.
Leukemia
|
January 15, 2010
Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone
H Avet-Loiseau, J Soulier, J-P Fermand, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
September 30, 2018
Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia
A L Roupie, M Battistella, A Talbot, et al.
Transfusion
|
March 10, 2001
Cytokines and vascular cell adhesion molecule-1 in the blood of patients undergoing HPC mobilization
C Dosquet, Y Chen, J Makke, et al.
Blood
|
October 27, 1998
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial
J P Fermand, P Ravaud, S Chevret, et al.
Leukemia
|
August 27, 2005
Fludarabine plus cyclophosphamide in Waldenström's macroglobulinemia: results in 49 patients
J Tamburini, V Lévy, C Chaleteix, et al.
Bone Marrow Transplantation
|
April 20, 2010
Tandem autologous non-myeloablative allogeneic transplantation in patients with multiple myeloma relapsing after a first high dose therapy
L Karlin, B Arnulf, S Chevret, et al.
La Revue De Medecine Interne
|
May 2, 2017
[Classification and therapeutic management of monoclonal gammopathies of renal significance]
V Javaugue, I Bouteau, C Sirac, et al.
Page
of 10